Ward JE et al. |
PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. |
2004 |
Br. J. Pharmacol. |
pmid:14718259
|
Bishop-Bailey D et al. |
Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell line. |
2000 |
Br. J. Pharmacol. |
pmid:11030710
|
Du H et al. |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. |
2011 |
Br. J. Pharmacol. |
pmid:21501147
|
Bardelli C et al. |
Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands. |
2012 |
Br. J. Pharmacol. |
pmid:21745193
|
Wasinger C et al. |
Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. |
2014 |
Br. J. Pharmacol. |
pmid:25091578
|
Alves C et al. |
Effects of 15d-PGJâ‚‚-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. |
2011 |
Br. J. Pharmacol. |
pmid:20883476
|
Wright DH et al. |
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. |
1998 |
Br. J. Pharmacol. |
pmid:9579725
|
Davidson J et al. |
Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up-regulation of 15-deoxyΔ(12,14) prostaglandin J2 production. |
2013 |
Br. J. Pharmacol. |
pmid:23586396
|
Cuzzocrea S et al. |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. |
2003 |
Br. J. Pharmacol. |
pmid:12970094
|
Cuzzocrea S et al. |
The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. |
2003 |
Br. J. Pharmacol. |
pmid:12598422
|
Kane CJ et al. |
Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. |
2011 |
Brain Behav. Immun. |
pmid:21376806
|
Kim EJ et al. |
Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2. |
2002 |
Brain Res. |
pmid:12031542
|
Koppal T et al. |
Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells. |
2000 |
Brain Res. |
pmid:10837804
|
Ou Z et al. |
Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat. |
2006 |
Brain Res. |
pmid:16725118
|
Drew PD et al. |
Hormone regulation of microglial cell activation: relevance to multiple sclerosis. |
2005 |
Brain Res. Brain Res. Rev. |
pmid:15850670
|
Liu H et al. |
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. |
2003 |
Breast Cancer Res. Treat. |
pmid:12779083
|
Yee LD et al. |
The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells. |
2003 |
Breast Cancer Res. Treat. |
pmid:12725418
|
Kamagata C et al. |
15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. |
2007 |
Breast Cancer Res. Treat. |
pmid:17028981
|
Maurin AC et al. |
Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. |
2005 |
Calcif. Tissue Int. |
pmid:15868283
|
Liu J et al. |
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15838654
|
Nagata D et al. |
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. |
2008 |
Cancer Detect. Prev. |
pmid:18789607
|
Sabichi AL et al. |
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533896
|
Subbarayan V et al. |
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533897
|
Fu YG et al. |
Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1. |
2006 |
Cancer Lett. |
pmid:16412567
|
Qiao L et al. |
Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2. |
2008 |
Cancer Lett. |
pmid:18477501
|
Tan BS et al. |
6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). |
2013 |
Cancer Lett. |
pmid:23612072
|
Núñez NP et al. |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. |
2006 |
Cancer Lett. |
pmid:15979236
|
Siavash H et al. |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. |
2004 |
Cancer Lett. |
pmid:15194221
|
James SY et al. |
Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. |
2003 |
Cancer Res. |
pmid:12839938
|
Rubin GL et al. |
Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. |
2000 |
Cancer Res. |
pmid:10749129
|
Houston KD et al. |
Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. |
2003 |
Cancer Res. |
pmid:12649180
|
Vanaja DK et al. |
Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. |
2000 |
Cancer Res. |
pmid:10987274
|
Kim HJ et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. |
2007 |
Cancer Res. |
pmid:17363578
|
Badawi AF et al. |
Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. |
2004 |
Cancer Res. |
pmid:14871855
|
Grau R et al. |
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. |
2004 |
Cancer Res. |
pmid:15289320
|
Chinery R et al. |
Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. |
1999 |
Cancer Res. |
pmid:10364000
|
Zimmer M et al. |
The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. |
2010 |
Cancer Res. |
pmid:20354189
|
Park EY et al. |
Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. |
2004 |
Cancer Res. |
pmid:15150131
|
Millán O et al. |
Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis. |
2006 |
Carcinogenesis |
pmid:16113051
|
Pavan L et al. |
Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. |
2003 |
Carcinogenesis |
pmid:12807721
|
Kim DH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. |
2009 |
Carcinogenesis |
pmid:19136476
|
Kim EH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. |
2008 |
Carcinogenesis |
pmid:18192694
|
Viñals M et al. |
Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. |
2005 |
Cardiovasc. Res. |
pmid:15769457
|
Chintalgattu V et al. |
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. |
2007 |
Cardiovasc. Res. |
pmid:17320065
|
Ramji DP |
Growth hormone-releasing peptides, CD36, and stimulation of cholesterol efflux: cyclooxygenase-2 is the link. |
2009 |
Cardiovasc. Res. |
pmid:19520704
|
Tomita H et al. |
Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. |
2005 |
Cardiovasc. Res. |
pmid:15949477
|
Bujold K et al. |
CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. |
2009 |
Cardiovasc. Res. |
pmid:19377069
|
Chatterjee PK et al. |
The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. |
2004 |
Cardiovasc. Res. |
pmid:14962493
|
Nagy L et al. |
Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. |
1998 |
Cell |
pmid:9568715
|
Tontonoz P et al. |
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. |
1998 |
Cell |
pmid:9568716
|